Cystic fibrosis in the mouse by targeted insertional mutagenesis

J R Dorin1, P Dickinson, E W Alton

  • 1MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK.

Nature
|September 17, 1992
PubMed

Insights

Scientists created a mouse model for cystic fibrosis by disrupting the cystic fibrosis transmembrane conductance regulator gene. These mice exhibit key disease characteristics, offering a valuable tool for developing new cystic fibrosis therapies.

Area of Science:

  • Genetics
  • Physiology
  • Animal Models

Background:

  • Cystic fibrosis is a fatal genetic disorder affecting 50,000 individuals globally.
  • A validated animal model is crucial for understanding and treating cystic fibrosis.
  • The cystic fibrosis transmembrane conductance regulator (CFTR) gene is implicated in the disease.

Purpose of the Study:

  • To develop a mouse model for cystic fibrosis.
  • To validate the model's utility in studying disease mechanisms and testing therapies.

Main Methods:

  • Gene targeting was used to disrupt the mouse CFTR gene in embryonic stem cells.
  • Germ-line chimeras were generated, and heterozygous crosses were studied.
  • In vivo electrophysiology and histological analysis were performed on the offspring.

Main Results:

  • Homozygous mutant mice, lacking functional CFTR, survived beyond weaning.
  • Electrophysiology confirmed defective chloride ion transport, consistent with cystic fibrosis.
  • Histological analysis revealed pathologies in the colon, lung, and vas deferens, mirroring human disease.

Conclusions:

  • The developed insertional mouse mutation represents a valid animal model for cystic fibrosis.
  • This model is suitable for investigating disease pathogenesis and evaluating potential therapeutic interventions.

Related Concept Videos

Mutations01:39

Mutations

Overview
Protein and Protein Structure02:15

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Gene Conversion02:08

Gene Conversion

Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Mechanism of Filopodia Formation01:39

Mechanism of Filopodia Formation

Filopodia are thin, actin-rich cellular protrusions that play an important role in many fundamental cellular functions. They vary in their occurrence, length, and positioning in different cell types, suggesting their diverse roles.
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...